Effects of Semaglutide and Empagliflozin on Inflammatory Markers in Patients with Type 2 Diabetes

Low-grade inflammation is associated with complications of type 2 diabetes. Glucagon-like peptide-1 receptor agonists and sodium-glucose transporter-2 inhibitors have shown cardioprotective effects that are independent of their glucose-lowering effects. Cardio-protection could be mediated by the ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Reppo, Ingrid, Jakobson, Maili, Volke, Vallo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054691/
https://www.ncbi.nlm.nih.gov/pubmed/36982786
http://dx.doi.org/10.3390/ijms24065714

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054691/
https://www.ncbi.nlm.nih.gov/pubmed/36982786
http://dx.doi.org/10.3390/ijms24065714

Ejemplares similares